Esperion Therapeutics, Inc. (ESPR)
1.905
0.00 (0.00%)
USD |
NASDAQ |
Apr 29, 16:00
Esperion Therapeutics Research and Development Expense (TTM) : 47.85M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Nektar Therapeutics | 117.30M |
| Harrow, Inc. | 12.49M |
| Corcept Therapeutics, Inc. | 254.91M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |